Fabio Farinati

University of Padua — Italy

Medicine · Health Sciences

72h-index18.3kcitations724works4.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver Disease Diagnosis and Treatment(261), Hepatocellular Carcinoma Treatment and Prognosis(238), Helicobacter pylori-related gastroenterology studies(136), Liver Disease and Transplantation(94), Gastric Cancer Management and Outcomes(82)

Publications721 total

The current success of precision oncology relies on precision diagnostics: how quality and quantity of endoscopic biopsies impact cancer patient outcome
Digestive and Liver Disease·2025· 2 citedOpen Access
Differential target of oxidative damage in Helicobacter pylori-related and autoimmune atrophic gastritis: a single-center study
Frontiers in Medicine·2025Open Access
Clinical and Endoscopic-Histological Features of Multifocal and Corpus-Restricted Atrophic Gastritis Patients With Non-Cardia Gastric Cancer or Dysplasia: A Multicenter, Cross-Sectional Study
Clinical and Translational Gastroenterology·2025· 4 citedOpen Access
WED-138-YI Somatic copy number alterations in circulating cell-free DNA as a predictive biomarker for hepatocellular carcinoma: insights from a proof-of-concept study
Journal of Hepatology·2025
OC.10.4 SOMATIC COPY NUMBER ALTERATIONS IN CIRCULATING CELL-FREE DNA AS A PREDICTIVE BIOMARKER FOR HEPATOCELLULAR CARCINOMA: INSIGHTS FROM A PROOF-OF-CONCEPT STUDY
Digestive and Liver Disease·2025
BOC.03.4 THE PROGNOSTIC IMPACT OF COMORBIDITIES IN PATIENTS WITH HEPATOCELLULAR CARCINOMA: AN ANALYSIS OF THE ITA. LI.CA DATABASE
Digestive and Liver Disease·2025
Somatic Copy Number Alterations in Circulating Cell-Free DNA as a Prognostic Biomarker for Hepatocellular Carcinoma: Insights from a Proof-of-Concept Study
Cancers·2025· 2 citedOpen Access
Systemic inflammatory response markers improve the discrimination for prognostic model in hepatocellular carcinoma
Hepatology International·2025· 12 citedOpen Access
Somatic copy number alterations in circulating cell-free DNA as a predictive biomarker for hepatocellular carcinoma: insights from a proof-of-concept study
Digestive and Liver Disease·2025
<scp>DAA</scp>‐<scp>PASS</scp>: A Prospective Evaluation of <scp>HCC</scp> Recurrence After Direct Acting Antiviral Therapy
Journal of Viral Hepatitis·2025
Drug-Induced Liver Injury: Role of Circulating Liver-Specific microRNAs and Keratin-18
Gastroenterology Insights·2024· 2 citedOpen Access
Systemic Inflammatory Response Markers Improve the Discrimination for Prognostic Model in Hepatocellular Carcinoma
2024Open Access
Hierarchically Positioning Laparoscopic Microwave Ablation in the Therapeutic Span of Early Hepatocellular Carcinoma: A Real-Life Comparative Analysis
Annals of Surgical Oncology·2024· 3 cited
Distinguishing Features of Autoimmune Gastritis Depending on Previous Helicobacter pylori Infection or Positivity to Anti-Parietal Cell Antibodies: Results From the Autoimmune gastRitis Italian netwOrk Study grOup (ARIOSO)
The American Journal of Gastroenterology·2024· 22 cited
1047 EFFECT OF SCREENING STRATEGIES ON THE NATURAL HISTORY OF IBD-RELATED AND SPORADIC COLORECTAL CANCER
Gastroenterology·2024
Gastric cancer screening in Western countries: A call to action
Digestive and Liver Disease·2024· 21 citedOpen Access
Crosstalk between MicroRNAs and Oxidative Stress in Coeliac Disease
Inflammatory Intestinal Diseases·2024· 7 citedOpen Access
Multidisciplinary treatment of hepatocellular carcinoma in 2023: Italian practice Treatment Guidelines of the Italian Association for the Study of the Liver (AISF), Italian Association of Medical Oncology (AIOM), Italian Association of Hepato-Bilio-Pancreatic Surgery (AICEP), Italian Association of Hospital Gastroenterologists (AIGO), Italian Association of Radiology and Clinical Oncology (AIRO), Italian Society of Pathological Anatomy and Diagnostic Cytology (SIAPeC-IAP), Italian Society of Surgery (SIC), Italian Society of Gastroenterology (SIGE), Italian Society of Medical and Interventional Radiology (SIRM), Italian Organ Transplant Society (SITO), and Association of Patients with Hepatitis and Liver Disease (EpaC) – Part II – Non-surgical treatments
Digestive and Liver Disease·2023· 18 citedOpen Access
Multidisciplinary Treatment of Hepatocellular Carcinoma in 2023: Italian practice Treatment Guidelines of the Italian Association for the Study of the Liver (AISF), Italian Association of Medical Oncology (AIOM), Italian Association of Hepato-Bilio-Pancreatic Surgery (AICEP), Italian Association of Hospital Gastroenterologists (AIGO), Italian Association of Radiology and Clinical Oncology (AIRO), Italian Society of Pathological Anatomy and Diagnostic Cytology (SIAPeC-IAP), Italian Society of Surgery (SIC), Italian Society of Gastroenterology (SIGE), Italian Society of Medical and Interventional Radiology (SIRM), Italian Organ Transplant Society (SITO), and Association of Patients with Hepatitis and Liver Disease (EpaC) – Part I – Surgical treatments
Digestive and Liver Disease·2023· 23 citedOpen Access
HIF-1α and VEGF as prognostic biomarkers in hepatocellular carcinoma patients treated with transarterial chemoembolization
Digestive and Liver Disease·2023· 28 citedOpen Access
page 1 of 37Next →

Frequent Co-authors

Franco Trevisani(20), Marco Zoli(17), Edoardo G. Giannini(16), Franco Borzio(14), Eugenio Caturelli(14), Umberto Cillo(12), Luisa Benvegnù(12), Alessandro Vitale(10), R. Naccarato(10), P. Del Poggio(9), Massimo Rugge(9), Romilda Cardin(8), Maria Anna Di Nolfo(8), Giuseppe Cabibbo(8), Antonio Gasbarrini(8), Rodolfo Sacco(8), Francesco Giuseppe Foschi(8), Filomena Morisco(8), Patrizia Burra(7), Mauro Bernardi(7)